Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221390 | SCV000270348 | likely benign | not specified | 2017-05-16 | criteria provided, single submitter | clinical testing | p.Tyr85Tyr in exon 4 of LARS2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.2% (259/126146) o f European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomAD .broadinstitute.org; dbSNP rs114881088). |
Gene |
RCV000992266 | SCV000533820 | likely benign | not provided | 2020-09-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000992266 | SCV001144419 | benign | not provided | 2019-02-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000992266 | SCV001746461 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | LARS2: BP4, BP7 |
Invitae | RCV000992266 | SCV002455339 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003907807 | SCV004720945 | likely benign | LARS2-related condition | 2019-11-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |